COSCIENS Biopharma Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $22.4M | $20.0M | $7.8M |
| FY2020 | $23.8M | $37.0M | $24.3M |
| FY2021 | $58.2M | $80.1M | $6.2M |
| FY2022 | $4.0M | $27.8M | $10.2M |
| FY2023 | $2.7M | $23.7M | $6.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $22.4M | $20.0M | $7.8M |
| FY2020 | $23.8M | $37.0M | $24.3M |
| FY2021 | $58.2M | $80.1M | $6.2M |
| FY2022 | $4.0M | $27.8M | $10.2M |
| FY2023 | $2.7M | $23.7M | $6.7M |